MedTrace Logo

Treatment of Elevated Blood Pressures in Early Pregnancy

NCT05955040 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2024-11-21

No results posted yet for this study

Summary

This is a randomized controlled trial comparing the outcomes of treatment and non-treatment of elevated blood pressures in early pregnancy.

Conditions

  • Elevated Blood Pressure
  • Pregnancy Induced Hypertension

Interventions

DRUG

Nifedipine

Standard of care for treatment of elevated blood pressure during pregnancy

DRUG

Labetalol

Standard of care for treatment of elevated blood pressure during pregnancy

Sponsors & Collaborators

  • Marshall University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-11
Primary Completion
2024-05-06
Completion
2024-05-06
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05955040 on ClinicalTrials.gov